Results 41 to 50 of about 12,784,255 (313)

Gene-targeted therapies: Value, affordability, and access

open access: yes, 2023
A summary of three presentations from the United States’ National Center for Advancing Translational Sciences’ 2021 virtual conference on “Gene-Targeted Therapies: Early Diagnosis and Equitable Delivery” was recently published in the American Journal of ...
bartosb
core   +1 more source

The importance of being CAFs (in cancer resistance to targeted therapies)

open access: yesJournal of experimental & clinical cancer research : CR, 2022
In the last two decades, clinical oncology has been revolutionized by the advent of targeted drugs. However, the efficacy of these therapies is significantly limited by primary and acquired resistance, that relies not only on cell-autonomous mechanisms ...
S. Rizzolio, S. Giordano, S. Corso
semanticscholar   +1 more source

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials

open access: yesCancers, 2021
Simple Summary This review describes in a very detailed and exhaustive approach the literature of these last 20 years on glioblastoma targeted therapies in Phases II-IV of 257 clinical trials on adults with newly diagnosed or recurrent GBMs (excluding ...
Elisabete Cruz da Silva   +4 more
semanticscholar   +1 more source

Washed Microbiota Transplantation Lowers Blood Pressure in Patients With Hypertension

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
BackgroundAlthough transplantation of the fecal microbiota from normotensive donors has been shown to have an antihypertensive effect in hypertensive animal models, its effect on blood pressure in patients with hypertension is unclear.
Hao-Jie Zhong   +9 more
doaj   +1 more source

Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer

open access: yesCancer research and treatment : official journal of Korean Cancer Association, 2022
Precision oncology has fundamentally changed how we diagnose and treat cancer. In recent years, there has been a significant change in the management of patients with oncogene-addicted advanced-stage non–small cell lung cancer (NSCLC). Increasing amounts
J. Rivera-Concepcion   +2 more
semanticscholar   +1 more source

Translating Autoimmune Pathogenesis into Targeted Therapies for Systemic Sclerosis [PDF]

open access: yes, 2017
Targeted therapies including tumour necrosis factor α (TNFα) inhibitors have transformed the management of a number of autoimmune conditions over the past 20 years.
Mark D. Russell   +3 more
core   +1 more source

Targeted Therapies in Lung Cancer

open access: yes, 2022
An ongoing research and multiple clinical trials involve new targeted therapies and less aggressive treatment regimens that improve survival in patients with lung cancer.
Chirieac, Lucian, Dacic, Sanja
core   +1 more source

Intrinsic subtypes and therapeutic decision-making in hormone receptor-positive/HER2-negative metastatic breast cancer with visceral crisis: A case report

open access: yesFrontiers in Oncology, 2022
BackgroundCDK4/6 inhibitors (CDKi), namely, palbociclib, ribociclib, and abemaciclib, combined with either an aromatase inhibitor (AI) or fulvestrant are the standard first/second line for hormone receptor-positive(HR+)/HER2-negative(neg) metastatic ...
Francesco Schettini   +27 more
doaj   +1 more source

RAS-targeted therapies: is the undruggable drugged?

open access: yesNature reviews. Drug discovery, 2020
RAS (KRAS, NRAS and HRAS) is the most frequently mutated gene family in cancers, and, consequently, investigators have sought an effective RAS inhibitor for more than three decades.
Amanda R. Moore   +3 more
semanticscholar   +1 more source

Resistance to Molecularly Targeted Therapies in Melanoma

open access: yesCancers, 2021
Simple Summary Metastatic melanoma has poor survival rates in comparison to other types of skin cancer. Traditional therapies are not very effective in treating advanced melanoma.
Meet Patel   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy